Assessing patient wellness: New perspectives on quality of life and compliance

American Journal of Hypertension

Volumn 11, Issue 11 II SUPPL., 1998, Pages

  Williams, Gordon H ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antihypertensive therapy; Compliance; Hypertension; Quality of life

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTICLE; HEALTH STATUS; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; UNITED STATES;

EID: 0031736558     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(98)00196-4     Document Type: Article

References (27)

1. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967;202:116-122.
2. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg. JAMA 1970;213:1143-1152.
3. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to the incidence of major coronary events. Final report of the pooling project. J Chronic Dis 1978;31:201-306.
4. Hypertension Detection and Follow-Up Program Cooperative Group: Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2577.
5. Kannel WB, Dawber TR, McGee DL: Perspectives on systolic hypertension. The Framingham Study. Circulation 1980;61:1179-1182.
6. Hypertension Detection and Follow-Up Program Cooperative Group: The effect of treatment on mortality in "mild" hypertension. Results of the Hypertension Detection and Follow-Up Program. N Engl J Med 1982; 307:976-980.
7. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the US adult population. Results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
8. Burt VL, Cutler JA, Higgins M, et al: Trend in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69.
9. National Heart, Lung, and Blood Institute: Fact Book Fiscal Year 1996. U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD, 1997.
10. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-838.
11. Sagie A, Larson MG, Levy D: The natural history of borderline isolated systolic hypertension. N Engl J Med 1993;329:1912-1917.
12. Wilber JA, Barrow JG: Hypertension - a community problem. Am J Med 1972;52:653-663.
13. Miller NH, Hill M, Kottke T, et al: The multilevel compliance challenge: recommendations for a call to action. Circulation 1997;95:1085-1090.
14. Haynes RB: Management of patient compliance in the treatment of hypertension. Report of the NHLBI. Hypertension 1982;4:415-423.
15. Wenger NK, Mattson ME, Furberg CD, et al: Assessment of quality of life in clinical trials of cardiovascular therapies. Am J Cardiol 1984;54:908-913.
16. Croog SH, Levine S, Testa MA, et al: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314:1657-1664.
17. Levine S, Croog SH: Quality of life and the patient's response to treatment. J Cardiovasc Pharmacol 1985; 7(suppl 1):S132-S136.
18. Bulpitt CJ, Dollery CT, Carne S: Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976;38:121-128.
19. Jachuck SJ, Brierley H, Jachuck S, et al: The effect of hypotensive drugs on the quality of life. J R Coll Gen Pract 1987;82:98-105.
20. Testa MA, Hollenberg NK, Anderson RB, Williams GH: Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system. Am J Hypertens 1991;4:363-373.
21. Beto JA, Bansal VK: Quality of life in treatment of hypertension: a meta-analysis of clinical trials. Am J Hypertens 1992;5:125-133.
22. Hjemdahl P, Wiklund IK: Quality of life on antihypertensive drug therapy: scientific endpoint or marketing exercise? J Hypertens 1992;10:1437-1446.
23. Jern S, Aanchetti A: The issue of quality of life in antihypertensive therapy. J Hum Hypertens 1993; 1(suppl 7):S46-S49.
24. Testa MA, Anderson RB, Nackley JF, et al: Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. N Engl J Med 1993;328: 907-913.
25. Neaton JD, Grimm RH, Prineas RJ, et al: Treatment of mild hypertension study. Final results. JAMA 1993;270: 71-724.
26. Grimm RH, Grandits GA, Cutler JA, et al: Relationship of quality-of-life measures to long-term lifestyle and drug treatment in the treatment of mild hypertension study. Arch Intern Med 1997;157:638-648.
27. Anderson RB, Hollenberg NK, Williams GH: Physical symptoms distress index: a sensitive tool to evaluate the impact of pharmacologic agents on quality of life. Arch Int Med. 1998 (in press).